Sitemap

• Home
• About us
  • What we do
    • Pharmaceuticals
    • Vaccines
    • Consumer Healthcare
  • Our mission and strategy
  • Policies, codes and standards
• Products
  • Our prescription medicines and vaccines
  • Our consumer healthcare
    • To Sensodyne users
• Careers
  • Search jobs and apply
  • Areas of opportunity
    • Sales and Marketing
    • Other opportunities
  • Working at GSK
    • Developing our people
    • Employees helping communities
    • Employee health, safety and well-being
    • Inclusion and diversity
    • Our culture and values
    • Rewarding performance
  • Experienced professionals
  • Physicians
  • Postgraduates
  • Graduates
    • Vietnam University Campus
• Research
  • How we discover new medicines
  • Trials in people
    • Clinical trial phases
    • Become a clinical research volunteer
    • Independent clinical studies
  • Sharing our research
    • Clinical study register
    • Patient-level data
    • Open innovation
  • R&D locations
    • Europe
    • UK
    • USA & Canada
    • Asia
• Responsibility
  • Health for all
    • Access to healthcare
    • Tackling diseases in developing countries
    • HIV, AIDS and ViiV Healthcare
    • Health and well-being in communities
    • Investing in Least Developed Countries
    • Millennium Development Goals
    • Our commitments
  • Our behaviour
    • Sales and marketing practices
    • Public policy and patient advocacy
    • Ethical conduct and supply chain
    • Research practices
    • Our commitments
  • Our people
    • Global preventive health programme for employees
    • Working at GSK
    • Employee volunteering
    • Our commitments
  • Our planet
    • Carbon
    • Water
    • Waste and other impacts
    • Our commitments
  • Our stories
    • GSK antibiotics – Enduring trust
    • A turning point in digitalizing immunization management systems
    • Our Patient Care Mission
    • Training midwives
    • Water Safety
    • Uoc Mo Cua Thuy Fund
    • Pneumococcal
    • GSK/Novartis transaction
• Consumers
• Healthcare Professionals
  • Interactions with prescribers (sales and marketing)
  • Collaborating on clinical trials and research
  • Transparency disclosures
  • How GSK supports independent medical education
    • Disease areas of interest 2016-2017
    • Eligible independent medical education providers
    • Educational grant proposal review
    • How to apply
• Contact us
  • Our office sites
• Sitemap
• Terms of use
• Accessibility
• Cookie policy
• Privacy Statement
• Page not found
• Search
• News
  • GSK’s combination vaccine has returned to supply Vietnam
  • Thao's story
  • GSK names Hervé Gisserot as Head of Pharmaceuticals, Asia Pacific
  • GSK in partnership with Save The Children improves maternal and newborn healthcare services in Yen Bai province
  • GSK leads Access to Medicine Index 2016
  • Launching action plan to respond the "World COPD Day"
  • Do Not Let Children Die Because Of The Pneumonia
  • More healthcare solutions from U.S enterprises for Vietnam
  • GSK sets out further steps to address emerging global health security challenges
  • GSK and Save the Children call for developing country innovations to enter $1 million award
  • The app that could save lives
  • James Strenner, talks to FBNC about GSK’s progress
  • Live and attractive webcast CAUSE AND EFFECT: UNDERSTANDING THE INTERPLAY BETWEEN ALLERGIC RHINITIS AND ASTHMA
  • Letter to HCPs- Communication with HCPs about ERS travel sponsorship 2016 via 3rd Party
  • Inspiration Meeting 2016
  • About Asthma
  • Live webcast CAUSE AND EFFECT: UNDERSTANDING THE INTERPLAY BETWEEN ALLERGIC RHINITIS AND ASTHMA
  • Chief Represetative of GSK in Vietnam: "We are fostering efforts to support children's health"
  • PATH Vietnam wins share of global US$1 million Healthcare Innovation Award
  • Global HCP Engagement Initiative and Travel Sponsorship Programme